Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
180 results
D3.30 - Fixed drug eruption: exploring diagnostic considerations and triggers in a cohort study
D3.359 - Study of olfaction in patients with chronic rhinosinusitis with nasal polyposis undergoing Mepolizumab treatment
D3.395 - Evaluation for suspected penicillin allergy - the patient perspective
D3.47 - Implementing Penicillin Delabelling in an Inpatient setting
D3.49 - Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study
D3.50 - Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists
D3.51 - Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists
D3.56 - Relevant Aspects in the Investigation of Hypersensitivity Reactions to Non-Beta-Lactam Antibiotics
D3.57 - Isoniazid-Induced Lupus in a Filipino Female: A Case Report
D3.58 - Drug-Induced Enterocolitis Syndrome (DIES) Associated to Amoxicillin and Amoxicillin-Clavulanic Acid: A Growing Concern at a Tertiary Hospital
D3.59 - Insights from Drug Provocation Testing in Quinolone Allergy
D3.60 - Iodinated Contrast Media During Acute DRESS: A Hidden Risk for Future Drug Hypersensitivity?
D3.62 - Beta-Lactam Hypersensitivity: 5-year characterization of patients evaluated at the University of Chile Clinical Hospital
D3.63 - 5 Year Follow Up: Unveiling True Beta-Lactam Immediate Hypersensitivity in the University of Chile Clinical Hospital
D1.250 - Beyond the Label: A Multidisciplinary Effort to De-label Penicillin Allergy
D1.251 - Documentation of drug allergy in the Electronic Health Record (EHR) at a Tertiary paediatric allergy service in the UK
D1.252 - A model based economic evaluation to assess impact of Penicillin Allergy in COPD patients
D1.253 - Comparison of Immune-Related Adverse Events in Patients Treated with Atezolizumab and Durvalumab: A Critical Concern for Clinical Management
D1.254 - Assessing the Accuracy of Penicillin Allergy Labels in Paediatric Care: Focusing on Educational Gaps in Both Families and Healthcare Workers
D1.255 - Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q): A Cross-Cultural Adaptation and Reliability Study
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Current page
7
Page
8
Page
9
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download